{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T10:36:30Z","timestamp":1792146990613,"version":"4.4.0"},"reference-count":42,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:00:00Z","timestamp":1343347200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Haematol"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:title>Summary<\/jats:title><jats:p>The <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 (p53) pathway can be inhibited by <jats:italic><jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53<\/jats:italic> mutation or deletion or by <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>2 overexpression. Both occur in <jats:styled-content style=\"fixed-case\">B<\/jats:styled-content>urkitt lymphoma (<jats:styled-content style=\"fixed-case\">BL<\/jats:styled-content>), but many cases lack either abnormality. Expression patterns of the <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 inhibitor <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>4 have not been reported in <jats:styled-content style=\"fixed-case\">BL<\/jats:styled-content>, and increased <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>4 could deregulate the <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 pathway in cases without <jats:italic><jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53<\/jats:italic> or <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>2 abnormalities. We investigated <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 pathway disruption in paediatric <jats:styled-content style=\"fixed-case\">BL<\/jats:styled-content> patient samples (<jats:italic>n<\/jats:italic>\u00a0=\u00a030) by studying <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>4, <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>2, and <jats:styled-content style=\"fixed-case\">CDKN<\/jats:styled-content>1<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> (p21) protein and m<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> expression; <jats:italic><jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53<\/jats:italic> mutations; <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 protein expression; and gene copy number abnormalities. <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>4 protein was expressed in 30\/30 tumours, and <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>2 protein was weakly expressed in 7\/30 (23%). All cases were negative for <jats:styled-content style=\"fixed-case\">CDKN<\/jats:styled-content>1<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content> protein, and <jats:italic><jats:styled-content style=\"fixed-case\">CDKN<\/jats:styled-content>1<jats:styled-content style=\"fixed-case\">A<\/jats:styled-content><\/jats:italic> m<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> levels were decreased. <jats:italic><jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53<\/jats:italic> mutations were detected in 5\/28 (18%) cases and confirmed by sequencing. <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 protein was expressed in 15\/30 (50%) cases, including 7\/8 with <jats:italic><jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53<\/jats:italic> genetic alterations. <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>2 protein and m<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> expression levels did not correlate with lack of <jats:italic><jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53<\/jats:italic> genetic changes or <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 protein expression; however, there was an inverse relationship between detectable <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 protein expression and <jats:italic><jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>4<\/jats:italic> copy number gains and m<jats:styled-content style=\"fixed-case\">RNA<\/jats:styled-content> expression. The <jats:styled-content style=\"fixed-case\">TP<\/jats:styled-content>53 pathway is deregulated in paediatric <jats:styled-content style=\"fixed-case\">BL<\/jats:styled-content> cases, and increased <jats:styled-content style=\"fixed-case\">MDM<\/jats:styled-content>4 expression may be the primary mechanism in some cases.<\/jats:p>","DOI":"10.1111\/j.1365-2141.2012.09243.x","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T23:37:54Z","timestamp":1343432274000},"page":"763-771","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["<scp>TP<\/scp>53 pathway analysis in paediatric <scp>B<\/scp>urkitt lymphoma reveals increased <i><scp>MDM<\/scp>4<\/i> expression as the only <scp>TP<\/scp>53 pathway abnormality detected in a subset of cases"],"prefix":"10.1111","volume":"158","author":[{"given":"Vasiliki","family":"Leventaki","sequence":"first","affiliation":[{"name":"Department of Pathology University of Utah Health Sciences Center Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Rodic","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Utah Health Sciences Center Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl R.","family":"Tripp","sequence":"additional","affiliation":[{"name":"ARUP Laboratories Institute for Clinical and Experimental Pathology Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Bayerl","sequence":"additional","affiliation":[{"name":"Department of Pathology Penn State College of Medicine Hershey PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sherrie L.","family":"Perkins","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Utah Health Sciences Center Salt Lake City UT USA"},{"name":"ARUP Laboratories Institute for Clinical and Experimental Pathology Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phillip","family":"Barnette","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology University of Utah Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua D.","family":"Schiffman","sequence":"additional","affiliation":[{"name":"Department of Pediatric Hematology\/Oncology University of Utah Salt Lake City UT USA"},{"name":"Department of Oncological Sciences Huntsman Cancer Institute University of Utah Salt Lake City UT USA"},{"name":"Center for Children's Cancer Research (C3R) University of Utah Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney R.","family":"Miles","sequence":"additional","affiliation":[{"name":"Department of Pathology University of Utah Health Sciences Center Salt Lake City UT USA"},{"name":"ARUP Laboratories Institute for Clinical and Experimental Pathology Salt Lake City UT USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,7,27]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21206"},{"key":"e_1_2_6_3_1","first-page":"4273","article-title":"The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors","volume":"52","author":"Bhatia K.G.","year":"1992","journal-title":"Cancer Research"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08185.x"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2402402"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036665"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1201702"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.13.5835-5843.2004"},{"key":"e_1_2_6_9_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.13.20.2658"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/j.1460-2075.1991.tb07837.x"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.12.5413"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01633-07"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-007-0064-6"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.3800727"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc1012718"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.21.3707"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2008.312"},{"key":"e_1_2_6_18_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.01198-07"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e3181edf543"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08159.x"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20069"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature05194"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/modpathol.2009.170"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1044-579X(02)00058-5"},{"key":"e_1_2_6_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401912"},{"key":"e_1_2_6_26_1","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.03362"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1096-8652(199705)55:1<1::AID-AJH1>3.0.CO;2-Y"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1998.tb03822.x"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.24.1.186-191.2004"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-036673"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2008.312"},{"key":"e_1_2_6_32_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.4.812"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.274.12.8299"},{"key":"e_1_2_6_34_1","first-page":"1839","article-title":"Aberrant expression of HDMX proteins in tumor cells correlates with wild\u2010type p53","volume":"61","author":"Ramos Y.F.","year":"2001","journal-title":"Cancer Research"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403840"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08883.x"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2000.tb06705.x"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2012"},{"key":"e_1_2_6_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4129"},{"key":"e_1_2_6_40_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.10.3151.3151"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V82.10.3163.3163"},{"key":"e_1_2_6_42_1","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-08-0423"},{"key":"e_1_2_6_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2403254"}],"container-title":["British Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2141.2012.09243.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2141.2012.09243.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T21:56:28Z","timestamp":1695506188000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2141.2012.09243.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,27]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1365-2141.2012.09243.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09243.x","archive":["Portico"],"relation":{},"ISSN":["0007-1048","1365-2141"],"issn-type":[{"value":"0007-1048","type":"print"},{"value":"1365-2141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,27]]},"assertion":[{"value":"2012-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-06-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2012-07-27","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}